Publication

Publications in 2025

46.  Nesselbush M.C., … , Jeon YJ, …., Maximilian Diehn. An ultrasensitive method for detection of cell-free RNA.  Nature. 2025 Apr 16 [Impact Factor - 69.50]

45. Lee KW, Pham NT, Min HJ, Park HW, Lee JW, Lo HE, Kwon NY, Seo JM, Shaginyan I, Cho H, Wei L, Manavalan B*, Jeon YJ*. DOGpred: A Novel Deep Learning Framework for Accurate Identification of Human O-linked Threonine Glycosylation Sites. Journal of Molecular Biology. 2025 Mar 15. [Impact Factor – 4.7]

Publications in 2024

44.  Kim SY, Lee KW, Yoo YJ, Park SH, Lee JW, Jeon SH, Illia S, Joshi P, Park HW, Lo HE, Seo JM, Kim YW, Chang M, Lee TJ, Seo JB, Kim SH, Croce CM, Kim IK, Suh SS*,  Jeon YJ*.  MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer.  * Corresponding authors. Animal Cells and Systems. 2024 Apr 30

43. Moon SO, Lee KW, Park MS, Moon JH, Park SH, Kim SM, Hwang JH, Yoon JW, Jeon SM, Kim JS*, Jeon YJ*, Kweon DH*. 3-Fucosyllactose-Mediated Modulation of Immune Response against Virus Infection, * Corresponding authors. International Journal of Antimicrobial Agents, 2024 Apr 30

Publications in 2023

42.  Pham NT, Phan LT, Seo JM, Kim YW, Song MK*, Lee SC*, Jeon YJ*, Manavalan B*. Advancing the accuracy of SARS-CoV-2 phosphorylation site detection via meta-learning approach.  * Corresponding authors. Briefings in Bioinformatics. 2023 Dec 08

Publications in 2022

41.   Kim HJ, Suh SS, Park J, Shin MJ, Koo HM, Lee SJ, Jeon YJ, Lee S, Youn UJ, and Kim HJ. 7β-22 Dihydroxyhopane, Isolated from the Sub-Antarctic Lichen, Inhibits the Viability and Stemness in Glioma Stem Like Cells. OncoTargets and Therapy 

40.   Shin MJ, Chae HJ, Lee JW, Koo MH, Kim HJ, Seo JB, Illia S, Park SH, Lo HE, Kim SH, Youn YJ, Jeon YJ*, and Suh SS*. Lucidumol A, Purified Directly from Ganoderma lucidum, Exhibits Anticancer Effect and Cellular Inflammatory Response in Colorectal Cancer.
* Corresponding authors
Evidence-Based Complementary And Alternative Medicine [Impact factor - 2.650]

39. Park HW, Pitti T, Madhavan T, Jeon YJ*, Manavalan B*. MLACP 2.0: An updated machine learning tool for anticancer peptide prediction. * Corresponding authors Computational and Structural Biotechnology Journal [Impact factor - 6.155]

38. Jeon YJ*, Hasan MM, Park HW, Lee KW, Manavalan B*. TACOS: A novel approach for accurate prediction of cell-specific long non-coding RNAs subcellular localization. * Corresponding authors Briefings In Bioinformatics. 2022 Jul 18;23(4):bbac243. doi: 10.1093/bib/bbac243.  [Impact factor - 13.994] 

37. Hong YH, Aziz N, Park JG, Lee D, Kim JK, Kim SA, Choi W, Lee CY, Lee HP, Huyen Trang HT, Kim HG, Jeon YJ, Kim B, Kim Y, Kim KH, Yoo BC, Han JW, Parameswaran N, Kim JH, Hur H, Cho JY. EEF1AKMT3/MAP2K7/TP53 axis in gastric cancerThe EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer.  Cancer Letters, 2022 Jun 23;215803. doi: 10.1016/j.canlet.2022.215803. Online ahead of print.

Publications in 2021

36. Munkhjargal A, Kim MJ, Kim DY, Jeon YJ, Kee YH, Kim LK, Kim YH. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.  Int J Mol Sci. 2021 Jul 21;22(15):7782. doi: 10.3390/ijms22157782.

35. J Yeh M, …. , Jeon YJ, …. and Lee TJ. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.      Sci Rep. 2021 Apr 28;11(1):9219. doi: 10.1038/s41598-021-88615-8.

34. Jung JH, …., Jeon YJ, …., Woo J and Yang PC. miR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury.  Basic Res Cardiol. 2021 Mar 19;116(1):19. doi: 10.1007/s00395-021-00858-8.

33. Cha HR, …., Jeon YJ and Kim Y. Targeting Non-Oncogene Addiction for Cancer Therapy. Biomolecules 2021, 11(2), 129; https://doi.org/10.3390/biom11020129.  

32. Chae HJ, Seo JB, Kim SH, Jeon YJ* and Suh SS*. Fhit induces the reciprocal suppressions between Lin28/Let-7 and miR-17/92miR. Int. J. Med. Sci., 2021; 18(3): 706-714. doi: 10.7150/ijms.51429      * Corresponding author [Impact factor - 3.58]

Publications before 2020

31. Jeon YJ*, Binkely MS*, et.al. KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. * Equal Contribution Cancer Discovery 2020 Dec;10(12):1826-1841. doi: 10.1158/2159-8290.CD-20-0282. [Impact factor- 29.497] # Featured on the Cover

30. Nabet BY*, Esfahani MS*, …., Jeon YJ, …., Alizadeh AA#, Diehn M#. Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell.  2020 Oct 15;183(2):363-376.e13. doi: 10.1016/j.cell.2020.09.001. Epub 2020 Oct 1.

29. Kim SH, Jeon OK* and Jeon YJ*. Extracellular RNA: Emerging roles in cancer cell communication and biomarkers. Cancer Letters, 2020 Sep 8;495:33-40. doi: 10.1016/j.canlet.2020.09.002. Online ahead of print.    * Corresponding author [Impact factor - 8.679]

28. Park DJ, …. Jeon YJ, ….Ludwig T. Brca1 missense mutation in coiled-coil domain causes Fanconi Anemia in mice. Cancer Res. 2020 Oct 1;80(19):4172-4184. doi: 10.1158/0008-5472.CAN-20-0486.

27. Chabon JJ*, Hamilton EG*, Kurtz DM*, Esfahani MS*…. Jeon YJ…. Alizadeh AA and Diehn M. Integrating genomic features for non-invasive early lung cancer detection. Nature.  2020 Apr;580(7802):245-251. doi: 10.1038/s41586-020-2140-0. Epub 2020 Mar 25.

26. Jeon YJ*, Esfahani MS*, Lee L* , Flynn RA, Stehr H, Hui AB, Ishisoko N, Kildebeck E, Newman AM, Bratman SV, Porteus MH, Chang HY, Alizadeh AA and Diehn M. Functional Significance of U2AF1 S34F Mutations in Lung Adenocarcinoma. [Impact factor - 14.919] Nat Commun. 2019 Dec 13;10(1):5712. doi: 10.1038/s41467-019-13392-y. * Equal contribution

25. Lee H, …., Jeon YJ, …., and Jung YK. Promoting DR4-Ser424 O-GlcN 1 Acylation sensitizes TRAIL-tolerant persisters and TRAIL-resistant cancer cells to death. Cancer Research. 2019 Apr 15. pii: canres.1991.2018. doi: 10.1158/0008-5472.CAN-18-1991.

24. Jeon YJ, Kim S, Kim JH, Youn UJ and Suh S-S. The Comprehensive Roles of ATRANORIN, A Secondary Metabolite from the Antarctic Lichen Stereocaulon caespitosum, in HCC Tumorigenesis. [Impact factor - 4.411] Molecules. 2019 Apr 10;24(7). pii: E1414. doi: 10.3390/molecules24071414.

23. Jeon YJ*, Kim T*, Park D, Nuovo GJ, Rhee S, Joshi P, Lee BK, Jeong J, Suh S, Grotzke JE, Kim S, Song J, Sim H, Kim Y, Peng Y, Jeong Y, Garofalo M, Zanesi N, Kim J, Liang G, Nakano I, Cresswell P, Nana-Sinkam P, Cui R and Croce CM. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. [Impact factor - 14.919] Nat Commun. 2018 Nov 30;9(1):5110. doi: 10.1038/s41467-018-07561-8. * Equal contribution.

22. Shi L, …., Jeon YJ, ……., and Garofalo M. KRAS induces lung tumorigenesis through microRNAs modulation. Cell Death Dis. 2018 Feb 13;9(2):219

21. Ahn J, …. , Jeon YJ, …., and Lee K. Comparative expression profiling of testis-enriched genes regulated during the development of spermatogonial cells. PLoS One. 2017 Apr 17;12(4):e0175787. doi: 10.1371/journal.pone.0175787. eCollection 

20. Sun HL, …., Jeon YJ, …., and Croce CM. ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. Cancer Cell. 2016 Nov 14;30(5):723-736. doi: 10.1016/j.ccell.2016.10.001.

19. Hong SH, …., Jeon YJ, …., and Jung YK. APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis. Oncotarget. 2016 Mar 1. doi: 10.18632/oncotarget.7802

18. Kim SH, …., Jeon YJ, …., and Kim H. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Cell Death Differ. 2015 Sep;22(9):1517-25. doi: 10.1038/cdd.2015.7. Epub 2015 Feb 27.

17. Cui R, …., Jeon YJ, …., and Croce CM. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 2015 Sep 8;6(26):21802-15.

16. Cui R, …., Jeon YJ, …., and Croce CM (2015). MicroRNA-224 promotes tumor progression in non small cell lung cancer. Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4288-97. doi: 10.1073/pnas.1502068112.

15. Kim T, …., Jeon YJ, …., and Croce CM. MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression. Oncotarget. 2015 Aug 7;6(22):18780-9.

14. Jeon YJ*, Joshi P*, Laganà A, Middleton J, Secchiero P, Garofalo M, Croce CM. MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8650-5. doi: 10.1073/pnas.1500886112. * Equal Contribution [Impact Factor - 11.205]

13. Jeon YJ, Middleton J, Kim T, Laganà A, Piovan C, Secchiero P, Nuovo GJ, Cui R, Joshi P, Romano G, Di Leva G, Lee BK, Sun HL, Kim Y, Fadda P, Alder H, Garofalo M, Croce CM. A set of NF-κB-regulated microRNAs Induces Acquired TRAIL Resistance in Lung Cancer. Proc Natl Acad Sci U S A. published ahead of print 2015 Jun 15, doi:10.1073/pnas.1504630112 [Impact factor - 11.205]

12. Kim T*, Jeon YJ*, Cui R, Lee JH, Peng Y, Kim SH, Tili E, Alder H, Croce CM. Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis. J Natl Cancer Inst. 2015 Feb 6;107(4). * Equal Contribution [Impact factor - 13.506]

11. Joshi P, Middleton J, Jeon YJ, Garofalo M. MicroRNAs in lung cancer. World J Methodol. 2014 Jun 26;4(2):59-72. Review. [Impact Factor & Rank - Not Reported]

10. Kim T, …., Jeon YJ, ……., Croce CM. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4173-8.

9. Peng Y, …., Jeon YJ, …., Croce CM. Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proc Natl Acad Sci U S A.  2013 Sep 10;110(37):15043-8.

8. Garofalo M*, Jeon YJ*, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G Romano G, Crawford M, Nana-Sinkam P, Croce CM. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. * Equal Contribution [Impact factor – 4.015] PLoS One. 2013 Jun 21;8(6):e67581. doi: 10.1371/journal.pone.006758

7. Oh Y, Jeon YJ, …., Jung YK. Regulation in the targeting of TRAIL Receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells. Cell Death Differ. 2012 Jul;19 (7):1196-207.

6.  Suh SS, …., Jeon YJ, …., Croce CM. MicroRNAs/TP53 Feedback Circuitry in Glioblastoma Multiforme. Proc Natl Acad Sci U S A. 2012 Apr 3;109 (14):5316-21

5. Garofalo M*, Romano G*, Di Leva G*, Jeon YJ, …., and Croce CM. EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med. 2011 Dec 11;18(1):74-82.

4. Kim T, …., Jeon YJ, …., and Croce CM. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011 May 9;208(5):875-83.

3. Jeon YJ*, Kim IK*, Hong SH, Nan H, Kim HJ, Lee HJ, Masuda ES, Meyuhas O, Oh BH, Jung YK. Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene. 2008 Jul 17;27(31):4344-52. * Equal Contribution [Impact factor - 6.371]

2. Lee HJ, …., Jeon YJ, …., and Jung YK. AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol. 2007 Nov; 9:1303-1310.

1. Chang JW, Jeon YJ, …., and Jung YK. Neuronal vulnerability of CLN3 deletion to calcium-induced cytotoxicity is mediated by calsenilin. Hum Mol Genet. 2007 Feb; 16: 317-26.